1. Home
  2. HCWB vs WATT Comparison

HCWB vs WATT Comparison

Compare HCWB & WATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • WATT
  • Stock Information
  • Founded
  • HCWB 2018
  • WATT 2012
  • Country
  • HCWB United States
  • WATT United States
  • Employees
  • HCWB N/A
  • WATT N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • WATT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • HCWB Health Care
  • WATT Technology
  • Exchange
  • HCWB Nasdaq
  • WATT Nasdaq
  • Market Cap
  • HCWB 10.8M
  • WATT 9.3M
  • IPO Year
  • HCWB 2021
  • WATT 2014
  • Fundamental
  • Price
  • HCWB $3.45
  • WATT $8.01
  • Analyst Decision
  • HCWB Strong Buy
  • WATT
  • Analyst Count
  • HCWB 1
  • WATT 0
  • Target Price
  • HCWB $35.00
  • WATT N/A
  • AVG Volume (30 Days)
  • HCWB 30.0K
  • WATT 55.9K
  • Earning Date
  • HCWB 08-18-2025
  • WATT 07-29-2025
  • Dividend Yield
  • HCWB N/A
  • WATT N/A
  • EPS Growth
  • HCWB N/A
  • WATT N/A
  • EPS
  • HCWB N/A
  • WATT N/A
  • Revenue
  • HCWB $832,841.00
  • WATT $1,976,000.00
  • Revenue This Year
  • HCWB $178.36
  • WATT $1,028.91
  • Revenue Next Year
  • HCWB N/A
  • WATT $117.65
  • P/E Ratio
  • HCWB N/A
  • WATT N/A
  • Revenue Growth
  • HCWB N/A
  • WATT 434.05
  • 52 Week Low
  • HCWB $2.77
  • WATT $3.67
  • 52 Week High
  • HCWB $100.80
  • WATT $81.00
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 31.06
  • WATT 40.36
  • Support Level
  • HCWB $2.77
  • WATT $7.04
  • Resistance Level
  • HCWB $4.65
  • WATT $8.41
  • Average True Range (ATR)
  • HCWB 0.36
  • WATT 0.93
  • MACD
  • HCWB -0.09
  • WATT -0.19
  • Stochastic Oscillator
  • HCWB 36.22
  • WATT 23.47

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About WATT Energous Corporation

Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs, and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. The WPN technology provides a comprehensive suite of capabilities designed to power the next generation of wireless energy networks, seamlessly delivering power and data across diverse, battery-free device ecosystems. It enhances operational visibility, control, and intelligent business automation. Its products include Transmitter IC & Module, Receivers IC, Transmitter System, and Evaluation Kits.

Share on Social Networks: